Log in to your Inderes Free account to see all free content on this page.
Create account

Newbury Pharmaceuticals

1.38 SEK

+1.10 %

Less than 1K followers

NEWBRY

First North Stockholm

Medical Equipment & Services

Health Care

+1.10 %
+25.00 %
+22.77 %
+19.57 %
-30.20 %
-56.35 %
-75.62 %
-
-89.09 %

Newbury Pharmaceuticals is a pharmaceutical company. The company develops a pipeline of in-house developed and licensed products with a focus on specialty drugs in areas such as oncology, rare diseases, and neurology. The company conducts its business within the Scandinavian market. Newbury Pharmaceuticals was founded in 2020 and has its headquarters in Lund.

Read more
Market cap
41.8M SEK
Turnover
4.13K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
8.7.
2026

Interim report Q3'26

28.10.
2026

Annual report '26

20.1.
2027

General meeting '27

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.